Center for Biologics Evaluation and Research

FDA research center

Follow Center for Biologics Evaluation and Research on Notably News to receive short updates to your email — rarely!

January 2025 Peter Marks' directorship ended, and Vinay Prasad became the director of CBER.
2020 During the COVID-19 pandemic, the Vaccines and Related Biological Products Advisory Committee (VRBPAC) received significant media attention as it reviewed COVID-19 vaccines before their approval.
December 12 2017 The Food Advisory Committee was terminated.
June 9 2016 The Transmissible Spongiform Encephalopathies Advisory Committee was terminated.
January 2016 Karen Midthun concluded her directorship, and Peter Marks became the new director of CBER.
February 15 2015 The Antiviral Drugs Advisory Committee was terminated.
September 24 2013 The Veterinary Medicine Advisory Committee was terminated.

This contents of the box above is based on material from the Wikipedia article Center for Biologics Evaluation and Research, which is released under the Creative Commons Attribution-ShareAlike 4.0 International License.

See Also